Rocaltrol (Calcitriol)

Rocaltrol is an active form of Vitamin D3 commonly prescribed to treat conditions related to calcium and bone metabolism. Originally developed by the Swiss pharmaceutical giant Hoffmann-La Roche, it has become a staple in metabolic bone disease therapy worldwide. While the brand was founded and nurtured in Switzerland, manufacturing occurs in various specialized facilities across the globe to meet international medical standards. Ownership remains under the Roche Group, a multinational healthcare company headquartered in Basel, which continues to manage its global distribution and research. The brand is recognized for its heritage in Swiss pharmaceutical innovation and precision.